NO923953D0 - Peptider - Google Patents
PeptiderInfo
- Publication number
- NO923953D0 NO923953D0 NO923953A NO923953A NO923953D0 NO 923953 D0 NO923953 D0 NO 923953D0 NO 923953 A NO923953 A NO 923953A NO 923953 A NO923953 A NO 923953A NO 923953 D0 NO923953 D0 NO 923953D0
- Authority
- NO
- Norway
- Prior art keywords
- peptides
- elicit
- fragments
- compositions
- cancer
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 108700020796 Oncogene Proteins 0.000 abstract 1
- 102000043276 Oncogene Human genes 0.000 abstract 1
- 238000011394 anticancer treatment Methods 0.000 abstract 1
- 229940022399 cancer vaccine Drugs 0.000 abstract 1
- 238000009566 cancer vaccine Methods 0.000 abstract 1
- 230000007969 cellular immunity Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO92923953A NO923953L (no) | 1991-02-26 | 1992-10-12 | Peptider |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919103974A GB9103974D0 (en) | 1991-02-26 | 1991-02-26 | Therapeutically useful peptides or peptide fragments |
PCT/NO1992/000032 WO1992014756A1 (en) | 1991-02-26 | 1992-02-21 | Therapeutically useful peptides and peptides fragments |
NO92923953A NO923953L (no) | 1991-02-26 | 1992-10-12 | Peptider |
Publications (2)
Publication Number | Publication Date |
---|---|
NO923953D0 true NO923953D0 (no) | 1992-10-12 |
NO923953L NO923953L (no) | 1993-03-26 |
Family
ID=10690575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92923953A NO923953L (no) | 1991-02-26 | 1992-10-12 | Peptider |
Country Status (14)
Country | Link |
---|---|
US (1) | US5961978A (no) |
EP (1) | EP0529023B1 (no) |
AT (1) | ATE181337T1 (no) |
AU (1) | AU660452B2 (no) |
CA (1) | CA2077537C (no) |
DE (1) | DE69229428T2 (no) |
DK (1) | DK0529023T3 (no) |
ES (1) | ES2134797T3 (no) |
FI (1) | FI108139B (no) |
GB (2) | GB9103974D0 (no) |
GR (1) | GR3031234T3 (no) |
HK (1) | HK1011370A1 (no) |
NO (1) | NO923953L (no) |
WO (1) | WO1992014756A1 (no) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2124595A1 (en) * | 1992-09-30 | 1994-04-14 | Hanswalter Zentgraf | Process for detecting p53-specific antibodies |
WO1994021287A1 (en) * | 1993-03-15 | 1994-09-29 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Peptide coated dendritic cells as immunogens |
AT399656B (de) * | 1993-03-19 | 1995-06-26 | Boehringer Ingelheim Int | Verfahren zur herstellung von krebsvakzinen |
GB9422814D0 (en) * | 1994-11-11 | 1995-01-04 | Medinnova Sf | Chemical method |
US6156316A (en) * | 1995-05-08 | 2000-12-05 | Sloan-Kettering Institute For Cancer Research | Oncogene fusion protein peptide vaccines |
US6365151B1 (en) | 1996-01-19 | 2002-04-02 | Philadelphia Health And Educational Corporation | Cellular immunogens comprising cognate proto-oxogenes |
US7709002B1 (en) * | 1996-04-19 | 2010-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes |
WO1997040156A1 (en) | 1996-04-19 | 1997-10-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
US6069229A (en) * | 1997-03-07 | 2000-05-30 | Schering Corporation | Mammalian proteinases; oxidoreductases; related reagents |
GB2328689A (en) * | 1997-08-27 | 1999-03-03 | Norsk Hydro As | Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer |
NO314086B1 (no) | 1998-05-08 | 2003-01-27 | Gemvax As | Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til |
NO315238B1 (no) | 1998-05-08 | 2003-08-04 | Gemvax As | Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy |
US7030211B1 (en) | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
NO309798B1 (no) * | 1999-04-30 | 2001-04-02 | Targovax As | Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen |
US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
GB0031430D0 (en) | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
GB0105238D0 (en) * | 2001-03-02 | 2001-04-18 | Norsk Hydro As | Vaccines |
CA2472282A1 (en) * | 2002-01-08 | 2003-07-17 | Chiron Corporation | Gene products differentially expressed in cancerous breast cells and their methods of use |
US20030206916A1 (en) * | 2002-05-03 | 2003-11-06 | Rush-Presbyterian-St. Luke's Medical Center | Immunogenic peptides |
US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
US7439042B2 (en) * | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
US7465454B2 (en) | 2002-12-16 | 2008-12-16 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
BRPI0516356A (pt) * | 2004-10-18 | 2008-09-02 | Globeimmune Inc | terapia à base de levedura para infecções crÈnicas da hepatite c |
US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
CN101448848B (zh) * | 2006-03-27 | 2013-12-04 | 全球免疫股份有限公司 | Ras突变及其相关组合物和方法 |
US20080079547A1 (en) * | 2006-09-29 | 2008-04-03 | Sensormatic Electronics Corporation | Radio frequency identification reader having a signal canceller and method thereof |
JP2012503011A (ja) | 2008-09-19 | 2012-02-02 | グローブイミューン,インコーポレイテッド | 慢性c型肝炎ウイルス感染の免疫療法 |
GB0821616D0 (en) | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
JP6781403B2 (ja) | 2013-12-09 | 2020-11-04 | タルゴバックス エーエスエー | ペプチド混合物 |
DK3140320T3 (en) * | 2014-05-06 | 2019-04-15 | Targovax Asa | PEPTID VACCINE CONTAINING MUTANT RACE PEPTID AND CHEMOTHERAPEUTIC AGENTS |
CN117224710A (zh) | 2017-02-01 | 2023-12-15 | 莫得纳特斯公司 | 编码活化致癌基因突变肽的免疫调节治疗性mrna组合物 |
EP3576764A4 (en) * | 2017-02-03 | 2020-12-16 | The Medical College of Wisconsin, Inc. | KRAS PEPTIDE VACCINE COMPOSITIONS AND METHOD OF USE |
JP2020522480A (ja) | 2017-06-02 | 2020-07-30 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ | 個別化された犬用癌ワクチンを作製する方法 |
WO2019055618A1 (en) | 2017-09-15 | 2019-03-21 | Arizona Board Of Regents On Behalf Of Arizona State University | METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY |
SG11202008433QA (en) * | 2018-03-02 | 2020-09-29 | Elicio Therapeutics Inc | Compounds including a mutant kras sequence and a lipid and uses thereof |
CN109550044B (zh) * | 2018-10-19 | 2022-05-03 | 杭州纽安津生物科技有限公司 | 通用性多肽疫苗及其在制备治疗/预防胰腺癌药物中的应用 |
WO2021067550A1 (en) | 2019-10-02 | 2021-04-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
US11058751B1 (en) | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1252046A (en) * | 1982-11-04 | 1989-04-04 | Martin J. Cline | Methods for oncogenic detection |
CA1219232A (en) * | 1983-08-17 | 1987-03-17 | Richard A. Lerner | Polypeptide-induced monoclonal receptors to protein ligands |
US4898932A (en) * | 1985-01-29 | 1990-02-06 | E. I. Du Pont De Nemours And Company | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
CA1296660C (en) * | 1985-01-29 | 1992-03-03 | Walter P. Carney | Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
US5100664A (en) * | 1985-09-20 | 1992-03-31 | Cetus Corporation | Human IL-2 as a vaccine adjuvant |
DK354487A (da) * | 1986-07-11 | 1988-01-12 | Noboru Yanaihara | Oncogen-relaterede peptider |
CA1339069C (en) * | 1987-11-09 | 1997-07-29 | Henry Lee Niman | Polypeptide-induced monoclonal receptors to protein ligand |
US4957859A (en) * | 1988-02-16 | 1990-09-18 | Hoffmann-La Roche Inc. | Antibodies for transforming ras protein |
WO1989008710A1 (en) * | 1988-03-08 | 1989-09-21 | E.I. Du Pont De Nemours And Company | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
JPH0816679B2 (ja) * | 1988-04-22 | 1996-02-21 | オンコジーン・サイエンス・インコーポレーテッド | 体液および組織におけるrasタンパクの検出、定量および分類 |
ATE160877T1 (de) * | 1988-08-12 | 1997-12-15 | Ligand Pharm Inc | Polypeptid-induzierte monoklonale rezeptoren gegen proteinliganden |
AU639311B2 (en) * | 1990-01-26 | 1993-07-22 | Washington Research Foundation | Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
-
1991
- 1991-02-26 GB GB919103974A patent/GB9103974D0/en active Pending
-
1992
- 1992-02-21 DE DE69229428T patent/DE69229428T2/de not_active Expired - Lifetime
- 1992-02-21 AU AU12729/92A patent/AU660452B2/en not_active Ceased
- 1992-02-21 WO PCT/NO1992/000032 patent/WO1992014756A1/en active IP Right Grant
- 1992-02-21 EP EP92905196A patent/EP0529023B1/en not_active Expired - Lifetime
- 1992-02-21 CA CA002077537A patent/CA2077537C/en not_active Expired - Lifetime
- 1992-02-21 DK DK92905196T patent/DK0529023T3/da active
- 1992-02-21 AT AT92905196T patent/ATE181337T1/de not_active IP Right Cessation
- 1992-02-21 ES ES92905196T patent/ES2134797T3/es not_active Expired - Lifetime
- 1992-02-26 GB GB9204098A patent/GB2253211A/en not_active Withdrawn
- 1992-09-11 FI FI924069A patent/FI108139B/fi active
- 1992-10-12 NO NO92923953A patent/NO923953L/no unknown
-
1995
- 1995-05-03 US US08/433,133 patent/US5961978A/en not_active Expired - Lifetime
-
1998
- 1998-11-30 HK HK98112448A patent/HK1011370A1/xx not_active IP Right Cessation
-
1999
- 1999-09-16 GR GR990402325T patent/GR3031234T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU660452B2 (en) | 1995-06-29 |
EP0529023A1 (en) | 1993-03-03 |
US5961978A (en) | 1999-10-05 |
DE69229428T2 (de) | 2000-06-29 |
CA2077537A1 (en) | 1992-08-27 |
HK1011370A1 (en) | 1999-07-09 |
GR3031234T3 (en) | 1999-12-31 |
GB9204098D0 (en) | 1992-04-08 |
AU1272992A (en) | 1992-09-15 |
GB2253211A (en) | 1992-09-02 |
NO923953L (no) | 1993-03-26 |
WO1992014756A1 (en) | 1992-09-03 |
GB9103974D0 (en) | 1991-04-10 |
ES2134797T3 (es) | 1999-10-16 |
CA2077537C (en) | 2000-06-13 |
FI108139B (fi) | 2001-11-30 |
FI924069A (fi) | 1992-09-11 |
FI924069A0 (fi) | 1992-09-11 |
ATE181337T1 (de) | 1999-07-15 |
DK0529023T3 (da) | 2000-01-17 |
DE69229428D1 (de) | 1999-07-22 |
EP0529023B1 (en) | 1999-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO923953L (no) | Peptider | |
DK0585943T3 (da) | Opløselige ligander for CD40 | |
MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
ATE212540T1 (de) | Antitumorvakzine | |
EP0541692A4 (en) | Herpes simplex virus vp16 vaccines | |
DE69824023D1 (de) | Peptide, die agonisten oder antagonisten des karzinoembrionalen antigens (cea) sind | |
NZ238833A (en) | Equine herpesvirus-4 gh or gc polypeptides, nucleic acids encoding them and vaccines therefrom | |
GB0004576D0 (en) | Proteins | |
ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung | |
ATE69549T1 (de) | Erzeugnisse, enthaltend gallopamil und prazosin. | |
NO20000976L (no) | Peptider | |
DK0427633T3 (da) | Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer | |
PT1173481E (pt) | Citoquinas inactivas para a imunização |